Literature DB >> 27408164

Toxic Epidermal Necrolysis Managed with Immunoglobulin.

G D Choudhury1, V Agarwal2.   

Abstract

Keywords:  Apoptosis; Drug reaction; Fas; Intravenous immunoglobulin

Year:  2011        PMID： 27408164      PMCID： PMC4921588          DOI： 10.1016/S0377-1237(08)80115-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  8 in total

1.  High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis.

Authors:  Elena Campione; Georgiana Clare Marulli; Anna Maria Carrozzo; Maria Sole Chimenti; Antonio Costanzo; Luca Bianchi
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

2.  Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression.

Authors:  K Ito; H Hara; T Okada; H Shimojima; H Suzuki
Journal:  Clin Exp Dermatol       Date:  2004-11       Impact factor: 3.470

Review 3.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

4.  High-dose intravenous immunoglobulins in the treatment of toxic epidermal necrolysis: an Asian series.

Authors:  Audrey W Tan; Bernard Y Thong; Leonard W Yip; Hiok Hee Chng; See Ket Ng
Journal:  J Dermatol       Date:  2005-01       Impact factor: 4.005

5.  Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.

Authors:  Mayumi Ueta; Chie Sotozono; Tsutomu Inatomi; Kentaro Kojima; Kei Tashiro; Junji Hamuro; Shigeru Kinoshita
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

6.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

7.  Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

Authors:  Amal Nassif; Homayoun Moslehi; Sabine Le Gouvello; Martine Bagot; Luc Lyonnet; Laurence Michel; Laurence Boumsell; Armand Bensussan; Jean-Claude Roujeau
Journal:  J Invest Dermatol       Date:  2004-11       Impact factor: 8.551

8.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728
  8 in total
  1 in total

Review 1.  Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Authors:  Audrey Jacobsen; Bayanne Olabi; Annie Langley; Jennifer Beecker; Eric Mutter; Amanda Shelley; Brandon Worley; Timothy Ramsay; Arturo Saavedra; Roses Parker; Fiona Stewart; Jordi Pardo Pardo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.